3566.html
Bantam Pharmaceutical Accelerates BTM-3566 Clinical Program Expanding Phase 1 Trial into Canada
Thu, 06 Mar 2025 05:00:00 GMT
Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced it is proceeding with a Phase 1 clinical trial ...
Bantam Pharmaceutical Accelerates BTM-3566 Clinical Program Expanding Phase 1 Trial into Canada
Wed, 05 Mar 2025 16:00:00 GMT
This clearance follows the recent activation of Bantam's first U.S. clinical trial site at The University of Texas MD Anderson Cancer Center for its BTM-3566 Phase 1 study. BTM-3566 is a first-in ...